An application of carbohydrate polymers-based surface-modified gold nanoparticles for improved target delivery to liver cancer therapy - A systemic review

Int J Biol Macromol. 2023 Dec 31;253(Pt 4):126889. doi: 10.1016/j.ijbiomac.2023.126889. Epub 2023 Sep 13.

Abstract

Gold nanoparticles have been broadly investigated as cancer diagnostic and therapeutic agents. Gold nanoparticles are a favorable drug delivery vehicle with their unique subcellular size and good biocompatibility. Chitosan, agarose, fucoidan, porphyran, carrageenan, ulvan and alginate are all examples of biologically active macromolecules. Since they are biocompatible, biodegradable, and irritant-free, they find extensive application in biomedical and macromolecules. The versatility of these compounds is enhanced because they are amenable to modification by functional groups like sulfation, acetylation, and carboxylation. In an eco-friendly preparation process, the biocompatibility and targeting of GNPs can be improved by functionalizing them with polysaccharides. This article provides an update on using carbohydrate-based GNPs in liver cancer treatment, imaging, and drug administration. Selective surface modification of several carbohydrate types and further biological uses of GNPs are focused on.

Keywords: Carbohydrates; Drug delivery; Gold nanoparticles; Liver cancer; Macromolecules; Surface modification.

Publication types

  • Systematic Review

MeSH terms

  • Carbohydrates
  • Gold
  • Humans
  • Liver Neoplasms* / drug therapy
  • Metal Nanoparticles* / therapeutic use
  • Nanoparticles*
  • Polymers

Substances

  • Gold
  • Polymers
  • Carbohydrates